- Home
- VNDA vs PMO Comparison
VNDA vs PMO Comparison
Compare VNDA & PMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VNDA
- PMO
- Stock Information
- Founded
- VNDA 2002
- PMO 1993
- Country
- VNDA United States
- PMO United States
- Employees
- VNDA N/A
- PMO N/A
- Industry
- VNDA Biotechnology: Pharmaceutical Preparations
- PMO Finance Companies
- Sector
- VNDA Health Care
- PMO Finance
- Exchange
- VNDA Nasdaq
- PMO Nasdaq
- Market Cap
- VNDA 249.4M
- PMO 287.4M
- IPO Year
- VNDA 2006
- PMO N/A
- Fundamental
- Price
- VNDA $4.39
- PMO $10.41
- Analyst Decision
- VNDA Strong Buy
- PMO
- Analyst Count
- VNDA 2
- PMO 0
- Target Price
- VNDA $16.50
- PMO N/A
- AVG Volume (30 Days)
- VNDA 346.2K
- PMO 99.0K
- Earning Date
- VNDA 11-05-2025
- PMO 01-01-0001
- Dividend Yield
- VNDA N/A
- PMO 4.10%
- EPS Growth
- VNDA N/A
- PMO N/A
- EPS
- VNDA N/A
- PMO 0.42
- Revenue
- VNDA $203,467,000.00
- PMO N/A
- Revenue This Year
- VNDA $15.45
- PMO N/A
- Revenue Next Year
- VNDA $37.82
- PMO N/A
- P/E Ratio
- VNDA N/A
- PMO $24.38
- Revenue Growth
- VNDA 11.78
- PMO N/A
- 52 Week Low
- VNDA $3.81
- PMO $8.57
- 52 Week High
- VNDA $5.55
- PMO $10.68
- Technical
- Relative Strength Index (RSI)
- VNDA 42.54
- PMO 77.03
- Support Level
- VNDA $4.36
- PMO $9.80
- Resistance Level
- VNDA $4.64
- PMO $10.39
- Average True Range (ATR)
- VNDA 0.16
- PMO 0.09
- MACD
- VNDA -0.03
- PMO 0.05
- Stochastic Oscillator
- VNDA 5.36
- PMO 85.92
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.
About PMO Putnam Municipal Opportunities Trust
Putnam Municipal Opportunities Trust is a non-diversified closed-end management investment company. It seeks to provide as high a level of current income free from federal income tax as Putnam Management believes is consistent with the preservation of capital. The fund invests in healthcare, utilities, transportation, tax bonds, local debt, state debt, and education.